Opendata, web and dolomites

PROOF SIGNED

Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PROOF project word cloud

Explore the words cloud of the PROOF project. It provides you a very rough idea of what is the project "PROOF" about.

stroke    sustaining    hyperoxygenation    treatments    significantly    flow    outcomes    core    ischaemia    secondary    hypoxia    mortality    leads    until    administered    intubation    trials    initiated       cognition    cell    health    tissue    curren    proves    reduces    shift    worldwide    24    neuronal    recanalization    penumbral    circulation    day    modified    blood    world    ease    center    penumbra    considering    volume    nihss    permil    arteries    onset    24h    randomized    logical    surrounding    criterion    fio2    therapeutic    undertaken    qol    risk    probe    standard    ischemic    iib    brain    50    reperfusion    morbidity    baseline    score    disruption    label    caused    attenuated    societal    mediated    care    nbho    supply    occlusion    oxygen    salvageable    categorical    accessible    models    blinded    seems    primarily    time    hypoperfused    proof    injury    normobaric    neuroprotective    adaptive    impacts    oelig    treatment    mask    vessel    infarction    biomarkers    hours    widen    proximal    35    surrogate    population    gt    animal    efficacy    100    pressure    endpoints    rebreather    patients    45    primary    minutes    endpoint    bridging    infarct    acirc    window    min    rankin    transient    anterior    death    economics    ventilation   

Project "PROOF" data sheet

The following table provides information about the project.

Coordinator
EBERHARD KARLS UNIVERSITAET TUEBINGEN 

Organization address
address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074
website: www.uni-tuebingen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.proof-trial.eu
 Total cost 5˙997˙347 €
 EC max contribution 5˙778˙827 € (96%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2016-RTD
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) coordinator 1˙498˙742.00
2    UNIVERSITATSKLINIKUM HEIDELBERG DE (HEIDELBERG) participant 1˙350˙776.00
3    EPPDATA GMBH DE (HAMBURG) participant 737˙875.00
4    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 679˙923.00
5    ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK FR (PARIS) participant 434˙733.00
6    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 321˙625.00
7    CENTRE HOSPITALIER SAINTE ANNE DE PARIS FR (PARIS CEDEX 14) participant 246˙814.00
8    VASTRA GOTALANDS LANS LANDSTING SE (VANERSBORG) participant 185˙600.00
9    HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ FI (HELSINKI) participant 137˙463.00
10    FAKULTNI NEMOCNICE U SV. ANNY V BRNE CZ (Brno) participant 118˙650.00
11    STROKE ALLIANCE FOR EUROPE BE (BRUSSELS) participant 66˙625.00
12    CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS CH (LAUSANNE) participant 0.00

Map

 Project objective

Ischemic stroke (IS), caused by occlusion of arteries that supply blood to the brain, remains a leading cause of mortality and morbidity in the world. Disruption of blood and oxygen supply to the brain leads to neuronal death in the ischemic core within minutes. The hypoperfused tissue surrounding the ischemic core, the penumbra, is at high risk for infarction over time but still salvageable. Neuroprotective “bridgingâ€Â, sustaining the penumbra until reperfusion, may widen the therapeutic window, make recanalization treatments accessible to more patients and improve overall IS outcomes. As ischemic cell death is primarily mediated by hypoxia, increasing oxygen supply to the penumbra seems THE logical approach. In animal models of IS, normobaric hyperoxygenation (NBHO) significantly increased penumbral oxygen pressure and attenuated brain injury when initiated early after onset of ischaemia and vessel occlusion was transient (35 to 50% infarct volume reduction). The PROOF project now seeks to demonstrate that NBHO (high-flow 100% oxygen at >45 L/min via a non-rebreather mask, or FiO2=1.0 for intubation/ventilation) reduces infarct growth from baseline to 24 hours compared to standard treatment if administered ≤3 hours after onset of anterior circulation IS, in patients with proximal vessel occlusion and salvageable tissue at risk. The study is multi-center, adaptive phase-IIb, randomized, open-label with blinded-endpoint (PROBE design). The primary efficacy criterion will be infarct growth from baseline to 24 hours. Secondary endpoints will be NIHSS 24h, categorical shift in the pre-stroke modified Rankin Score, QoL and cognition at day 90. Potential surrogate biomarkers, health economics and societal impacts will be assessed. If NBHO proves its neuroprotective potential in this selected population, phase-III trials in all IS patients may be undertaken. Considering its low costs and ease of use, NBHO may impact stroke care worldwide.

 Deliverables

List of deliverables.
PROOF communication and dissemination tools Documents, reports 2020-01-27 12:40:00
Final list of participating centres Documents, reports 2020-01-27 12:40:00
DSMB Formation Other 2020-01-27 12:40:00

Take a look to the deliverables list in detail:  detailed list of PROOF deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROOF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROOF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PD_Pal (2019)

Palliative care in Parkinson’s disease

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More